Replimune Group, Inc. Quarterly Operating Income (Loss) in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Replimune Group, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2017 to Q3 2024.
  • Replimune Group, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$58.9M, a 7.7% increase year-over-year.
  • Replimune Group, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$232M, a 8.16% decline year-over-year.
  • Replimune Group, Inc. annual Operating Income (Loss) for 2023 was -$235M, a 32.6% decline from 2022.
  • Replimune Group, Inc. annual Operating Income (Loss) for 2022 was -$177M, a 49.7% decline from 2021.
  • Replimune Group, Inc. annual Operating Income (Loss) for 2021 was -$118M, a 48% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$232M -$58.9M +$4.92M +7.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$236M -$57.4M -$1.72M -3.09% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$235M -$58.8M -$5.76M -10.9% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-16
Q4 2023 -$229M -$56.5M -$14.9M -35.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 -$214M -$63.8M -$22.3M -53.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$192M -$55.6M -$14.8M -36.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$177M -$53M -$21M -65.7% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-16
Q4 2022 -$156M -$41.6M -$11.9M -40.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 -$144M -$41.6M -$12.3M -42.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$132M -$40.9M -$13.5M -49.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$118M -$32M -$9.8M -44.2% Jan 1, 2022 Mar 31, 2022 10-K 2023-05-18
Q4 2021 -$109M -$29.7M -$9.42M -46.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-09
Q3 2021 -$99.1M -$29.2M -$9.58M -48.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$89.5M -$27.4M -$9.55M -53.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$80M -$22.2M -$5.8M -35.4% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-19
Q4 2020 -$74.2M -$20.3M -$3.61M -21.7% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-03
Q3 2020 -$70.5M -$19.7M -$7.42M -60.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$63.1M -$17.8M -$6.93M -63.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$56.2M -$16.4M -$8.56M -109% Jan 1, 2020 Mar 31, 2020 10-K 2021-05-20
Q4 2019 -$47.6M -$16.7M -$6.53M -64.4% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 -$41.1M -$12.2M -$5.14M -72.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$36M -$10.9M -$5.03M -85.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$30.9M -$7.83M -$761K -10.8% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-03
Q4 2018 -$30.2M -$10.1M -$5.41M -114% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$24.8M -$7.1M -$2.85M -66.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$21.9M -$5.88M -$2.7M -85.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$19.2M -$7.07M Jan 1, 2018 Mar 31, 2018 10-K 2020-06-03
Q4 2017 -$4.73M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$4.26M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$3.18M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.